glp-1 receptor agonists weight loss For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH GLP-1 Receptor Agonists for Weight
Description
Liraglutide Liraglutide, trade name Victoza, was developed by Novo Nordisk
Switching to oncedaily liraglutide from twicedaily exenatide further improves glycemic control in patients with type 2 diabetes using oral agents
But for over 40% of those on the medication, they also cause a sick-to-the-stomach feeling, aka nausea
This leads to a caloric deficit
And the overall contact time with the sublingual membrane decreases significantly
Ans: Ozempic dominated with approximately 35.12% share in 2025
